Top Markets
#1 CoW Protocol CoW Protocol +84.36%
#2 EXOD EXOD +56.80%
#3 Glidr Glidr +40.55%
#4 Walrus Walrus +32.30%
#5 Cysic Cysic +19.17%
#6 The Black Bull The Black Bull +15.59%
#7 Velvet Velvet +15.00%
#8 Arowana Arowana +14.93%
#9 Humanity Humanity +14.36%
#10 Huma Finance Huma Finance +14.07%
Coin of the day
CoW Protocol CoW Protocol
Settings
Language
ENGLISH
Currency
USD
Theme
The BC Bud Corporation The BC Bud Corporation

The BC Bud Corporation

BCBC
Rank in Stocks #37348
The BC Bud Corporation is a Canadian enterprise focused on the adult-use... The BC Bud Corporation is a Canadian enterprise focused on the adult-use cannabis market, specializing in the production, licensing, and distribution of cannabis goods. Its diverse product portfolio caters to various consumer preferences, including traditional dried cannabis flower. The company also offers a variety of edible formulations, such as its distinctive "Canna Beans" brand, which features chocolate-covered coffee beans infused with cannabis, alongside high-potency concentrates marketed under the "Solventless Solutions" label. Furthermore, they provide novel cannabis-infused beverages, specifically their "Buds" brand, designed to emulate the experience of drinking beer. Additionally, the company extends its brand presence through lifestyle apparel. The company maintains its headquarters in Vancouver, Canada.
Share Price
$0.03251057
Last synced: 2025-04-17
Market Cap
$1.80M
Change (1 day)
-9.90%
Change (1 year)
0.00%
Country
CA
Trade The BC Bud Corporation (BCBC)

Category

Healthcare
P/E ratio for The BC Bud Corporation (BCBC)
P/E ratio as of 2026 TTM: 0
According to The BC Bud Corporation latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for The BC Bud Corporation from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 38.29 -
IN
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.